Imeik Technology Development Co.,Ltd.

Shenzhen Stock Exchange 300896.SZ

Imeik Technology Development Co.,Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 17.80

Imeik Technology Development Co.,Ltd. Price to Sales Ratio (P/S) is 17.80 on January 14, 2025, a 6.52% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Imeik Technology Development Co.,Ltd. 52-week high Price to Sales Ratio (P/S) is 29.96 on October 08, 2024, which is 68.29% above the current Price to Sales Ratio (P/S).
Imeik Technology Development Co.,Ltd. 52-week low Price to Sales Ratio (P/S) is 11.42 on July 08, 2024, which is -35.82% below the current Price to Sales Ratio (P/S).
Imeik Technology Development Co.,Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 17.11.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shenzhen Stock Exchange: 300896.SZ

Imeik Technology Development Co.,Ltd.

CEO	Mr. Yifeng Shi
IPO Date	Sept. 28, 2020
Location	China
Headquarters	Shimao Building
Employees	910
Sector	Consumer Discretionary
Industries Cosmetics Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Imeik Technology Development Co.,Ltd focuses on the research and development, production, and sale of biomedical materials. The company offers medical beauty field products, including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. It also offers skin care products, including moisturizing lotions, anti-wrinkle firming kinetic energy liquids, essence creams, hydrating firming masks, chitosan B5 repair sprays, and purifying and brightening kinetic liquids. The company was founded in 2004 and is based in Beijing, China.

Key trends

Past 5 years